Catalogo dei Corsi di studio

Maria Ida Amabile received her M.D. cum laude in 2005 at Sapienza University of Rome, Italy, and she concluded cum laude in 2011 his residency/fellowship ( specialist ) in General Surgery. In 2013 she received a Research Fellowship in the field of breast cancer surgery and oncoplastic and reconstructive breast surgery at Institut Gustave Roussy Cancer Campus, France.
In 2015 she received her Ph.D. in Advanced Technologies in Surgery at Sapienza University of Rome.
In September 2015 she obtained the Inter-University Diplome (D.I.U.) of Surgical Senologic, Oncologic and Reconstructive Techniques (Experience in breast oncology surgery, deepening the techniques of breast cancer surgery and the indications and techniques of reconstructive surgery) at Institut Gustave Roussy Cancer Campus, and Paris Sud University, France.
She was post-doctoral research fellow (2015-2018) and from 2018 she is Assistant Professor of General Surgery at Sapienza University of Rome.
In the 2017 she received the grant awarded by the "Enrico and Enrica Sovena Foundation" for the Research Project entitled Sarcopenia in chirurgia oncologica: impatto delle modificazioni metaboliche e strutturali del muscolo sulla prognosi dei pazienti sottoposti a chirurgia addominale .
Since 2014 she has participated to several Research Projects granted by Sapienza University intramural research program.
By these grants, publications in peer-reviewed journals were obtained.
In the 2016-2018 session Dr. Amabile achieved the National Scientific Qualification as Associate Professor of General Surgery SSD MED/18, SC 06/C1.
Recent Clinical Trial Experience (2017-2021): Targeted nutritional intervention in Lung Cancer patients: randomized controlled trial; Characterising SARcopenia and sarcopenic obesity in patients Aged 65 years and over, at risk of mobility disability: OBServational Clinical Trial (SARA-OBS).
In summary, Dr. Maria Ida Amabile is conducting research in the field of Research activity in the field of: breast cancer and breast cancer surgery, in particular breast oncoplastic surgery and breast reconstructive surgery; metabolic-nutritional derangements in breast cancer patients and breast cancer surgery, in particular cancer-related, obesity and insulin-resistance; sarcopenia in oncological surgery to assess the impact of metabolic changes e muscle mass derangements on the prognosis of patients undergoing breast surgery. In particular, to examine the expression profiles of muscle-specific microRNAs in breast cancer patients and to evaluate their correlation with muscle mass and function and with post-operative complications.
Scopus (24.04.2021): h-index 11, citations 495 (first publication on Scopus in 2006).